Alhosani et al., 2024 - Google Patents
Transcriptome Profiling Associated with CARD11 Overexpression in Colorectal Cancer Implicates a Potential Role for Tumor Immune Microenvironment and Cancer …Alhosani et al., 2024
View HTML- Document ID
- 7621266087616318986
- Author
- Alhosani F
- Ilce B
- Alhamidi R
- Bhamidimarri P
- Hamad A
- Alkhayyal N
- Künstner A
- Khandanpour C
- Busch H
- Al-Ramadi B
- Sayed K
- AlFazari A
- Bendardaf R
- Hamoudi R
- Publication year
- Publication venue
- International journal of molecular sciences
External Links
Snippet
The immune system plays a critical role in inflammation by initiating responses to infections or tissue damage. The nuclear factor-κB (NF-κB) pathway plays a key role in inflammation and innate immunity, as well as other cellular activities. Dysregulation of this well …
- 206010009944 Colon cancer 0 title abstract description 158
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
- C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/12—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for modelling or simulation in systems biology, e.g. probabilistic or dynamic models, gene-regulatory networks, protein interaction networks or metabolic networks
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/28—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Luo et al. | Plasma level of circular RNA hsa_circ_0000190 correlates with tumor progression and poor treatment response in advanced lung cancers | |
Ravegnini et al. | Prognostic role of miR-221 and miR-222 expression in cancer patients: a systematic review and meta-analysis | |
Oshi et al. | A novel 4-gene score to predict survival, distant metastasis and response to neoadjuvant therapy in breast cancer | |
Foroughi et al. | Tissue-specific down-regulation of the long non-coding RNAs PCAT18 and LINC01133 in gastric cancer development | |
Auguste et al. | Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) beyond SMARCA4 mutations: a comprehensive genomic analysis | |
Gasparello et al. | A distinctive microRNA (miRNA) signature in the blood of colorectal cancer (CRC) patients at surgery | |
Ottaiano et al. | Evolution of mutational landscape and tumor immune-microenvironment in liver oligo-metastatic colorectal cancer | |
Hwang et al. | MicroRNA-1258 inhibits the proliferation and migration of human colorectal cancer cells through suppressing CKS1B expression | |
Matboli et al. | mRNA-miRNA-lncRNA regulatory network in nonalcoholic fatty liver disease | |
Wu et al. | ANLN and TLE2 in muscle invasive bladder cancer: a functional and clinical evaluation based on in silico and in vitro data | |
Wróblewska et al. | The potential role of selected miRNA in uveal melanoma primary tumors as early biomarkers of disease progression | |
Jeong et al. | Genome-wide methylation profiling in canine mammary tumor reveals miRNA candidates associated with human breast cancer | |
Guo et al. | The landscape of small non-coding RNAs in triple-negative breast cancer | |
Mutala et al. | The caspase-1/IL-18 axis of the inflammasome in tumor cells: A modulator of the Th1/Tc1 response of tumor-infiltrating T lymphocytes in colorectal cancer | |
Prouteau et al. | Canine oral melanoma genomic and transcriptomic study defines two molecular subgroups with different therapeutical targets | |
De Vitis et al. | B4GALT1 is a new candidate to maintain the stemness of lung cancer stem cells | |
Mudgapalli et al. | The transcribed-ultra conserved regions: novel non-coding RNA players in neuroblastoma progression | |
Chen et al. | KLF5 is activated by gene amplification in gastric cancer and is essential for gastric cell proliferation | |
Guglas et al. | YRNAs: New insights and potential novel approach in head and neck squamous cell carcinoma | |
Opławski et al. | Molecular Landscape of the Epithelial–Mesenchymal Transition in Endometrioid Endometrial Cancer | |
Chung et al. | PD-L1 Expression in High-Risk Early-Stage Colorectal Cancer—Its Clinical and Biological Significance in Immune Microenvironment | |
Aghiorghiesei et al. | Dysregulation of miR-21-5p, miR-93-5p, miR-200c-3p and miR-205-5p in oral squamous cell carcinoma: a potential biomarkers panel? | |
Kim et al. | Comprehensive gene expression analyses of immunohistochemically defined subgroups of muscle-invasive urinary bladder urothelial carcinoma | |
Stasiak et al. | The profile of microRNA expression and potential role in the regulation of drug-resistant genes in doxorubicin and topotecan resistant ovarian cancer cell lines | |
Garajei et al. | Evaluation of the expression of miR-486-3p, miR-548-3p, miR-561-5p and miR-509-5p in tumor biopsies of patients with oral squamous cell carcinoma |